Firmenbeschreibung
Qiagen N.V. ist eine niederländische Holdinggesellschaft und weltweit führend in der Entwicklung und Herstellung innovativer Technologien und Produkte für die präanalytische Probenvorbereitung und molekularbiologischen Tests für die Forschung in Life Sciences, dem Feld der angewandten Testverfahren und der molekularen Diagnostik. Das umfangreiche Portfolio des Unternehmens umfasst zahlreiche Produkte und Automationsplattformen für die Probenentnahme sowie die Trennung, Reinigung und Handhabung von Nukleinsäuren und Proteinen sowie Testtechnologien, die in der Form von offenen Nachweiskits und auch gezielten Tests für die angewandten Märkte und die molekulare Diagnostik angeboten werden. Qiagen-Produkte werden an wissenschaftliche Forschungsinstitute, Unternehmen im Pharma- und Biotechnologiebereich, an Kunden in angewandten Märkten (u.a. Forensik, Tier- und Nahrungsmittelkontrolle und der pharmazeutischen Prozesskontrolle) sowie an diagnostische Labore verkauft.
KeyData
| endOfFinancialYear: | 31.12.2022 00:00 |
| stockholderStructure: | Sun Life Financial, Inc. (MFS) (10.5%),BlackRock, Inc. (9.3%),The Vanguard Group, Inc. (3.9%),Norges Bank (2.9%),Rue la Boetie SAS (2.9%) |
| sharesOutstanding: | 228202755.0000 |
| ceo: | Thierry Bernard |
| board: | Roland Sackers, Fernando Beils, Stephany Foster, Antonio Santos, Nitin Sood, Dr. Jonathan Sheldon, Jean-Pascal Viola |
| supervisoryBoard: | Lawrence A. Rosen, Dr. Metin Colpan, Dr. Toralf Haag, Elizabeth E. Tallett, Prof. Dr. Elaine Mardis, Prof. Dr. Ross L. Levine, Dr. Eva Pisa, Steve Rusckowski, Bert van Meurs, Eva van Pelt |
| countryID: | 4 |
| freeFloat: | 60.0000 |
| sectorName: | Biotechnologie |
| industryName: | Biotechnologie |
| subsectorName: | Biotechnologie |
| country: | Niederlande |
| countryName: | Niederlande |
Kontakt
| name: | John Gilardi |
| phone: | +49-2103-29-11711 |
| email: | john.gilardi@qiagen.com |
| irWebSite: | https://corporate.qiagen.com/investor-relations/ |
Adresse
| street: | Spoorstraat 50 |
| city: | NL-5911 KJ Venlo |
| phone: | +31-77-320-8400 |
| fax: | +31-77-320-8409 |
| webSite: | www.qiagen.com |
| email: | qiagen@qiagen.com |
Finanzen (kurz)
| year: | 2021 | cash: | 880.5000 |
| balanceSheetTotal: | 6147.0000 | liabilities: | 3050.4000 |
| totalShareholdersEquity: | 3096.6000 | sales: | 2251.7000 |
| bankLoans: | 648.6000 | investment: | 9.6000 |
| incomeBeforeTaxes: | 625.8000 | netIncome: | 512.6000 |
| cashFlow: | 282.5000 | employees: | 6028 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
| year: | 2022 | cash: | 730.6600 |
| balanceSheetTotal: | 6287.7300 | liabilities: | 2821.1200 |
| totalShareholdersEquity: | 3466.6100 | sales: | 2141.5100 |
| investment: | 32.7500 | incomeBeforeTaxes: | 512.6000 |
| netIncome: | 423.2100 | employees: | 6178 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
| year: | 2023 | cash: | 668.0800 |
| balanceSheetTotal: | 6115.1900 | liabilities: | 2307.4200 |
| totalShareholdersEquity: | 3807.7600 | sales: | 1965.3100 |
| investment: | 78.9900 | incomeBeforeTaxes: | 429.8000 |
| netIncome: | 341.3000 | employees: | 5967 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
Finanzen (kurz)
| year: | 2021 |
| cash: | 880.5000 |
| balanceSheetTotal: | 6147.0000 |
| liabilities: | 3050.4000 |
| totalShareholdersEquity: | 3096.6000 |
| sales: | 2251.7000 |
| bankLoans: | 648.6000 |
| investment: | 9.6000 |
| incomeBeforeTaxes: | 625.8000 |
| netIncome: | 512.6000 |
| cashFlow: | 282.5000 |
| employees: | 6028 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2022 |
| cash: | 730.6600 |
| balanceSheetTotal: | 6287.7300 |
| liabilities: | 2821.1200 |
| totalShareholdersEquity: | 3466.6100 |
| sales: | 2141.5100 |
| investment: | 32.7500 |
| incomeBeforeTaxes: | 512.6000 |
| netIncome: | 423.2100 |
| employees: | 6178 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2023 |
| cash: | 668.0800 |
| balanceSheetTotal: | 6115.1900 |
| liabilities: | 2307.4200 |
| totalShareholdersEquity: | 3807.7600 |
| sales: | 1965.3100 |
| investment: | 78.9900 |
| incomeBeforeTaxes: | 429.8000 |
| netIncome: | 341.3000 |
| employees: | 5967 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2022 | units: | 1000000 |
| balanceSheetTotal: | 6287.7300 | cash: | 730.6600 |
| currentAssets: | 2393.9500 | fixedAssets: | 3893.7800 |
| liabilities: | 974.5200 | nonCurrentLiabilities: | 1846.6000 |
| totalLiabilitiesEquity: | 6287.7300 | provisions: | 486.2300 |
| totalShareholdersEquity: | 3466.6100 | employees: | 6178 |
| property: | 662.1700 | intangibleAssets: | 544.7900 |
| inventories: | 357.9600 | accountsReceivable: | 323.7500 |
| accountsPayable: | 98.7300 | liabilitiesTotal: | 2821.1200 |
| longTermDebt: | 1474.8900 | shortTermDebt: | 389.5500 |
| minorityInterests: | 0.0000 | sales: | 2141.5100 |
| netIncome: | 423.2100 | operatingResult: | 531.4600 |
| incomeInterest: | -25.6000 | investments: | 189.8500 |
| incomeTaxes: | 89.3900 | costGoodsSold: | 756.9500 |
| grossProfit: | 1384.5600 | minorityInterestsProfit: | 0.0000 |
| revenuePerEmployee: | 346634.8333 | cashFlow: | 715.2600 |
| cashFlowInvesting: | -726.7600 | cashFlowFinancing: | -125.8000 |
| accountingStandard: | US GAAP | equityRatio: | 55.1329 |
| debtEquityRatio: | 81.3798 | liquidityI: | 74.9764 |
| liquidityII: | 108.1979 | netMargin: | 19.7622 |
| grossMargin: | 64.6534 | cashFlowMargin: | 33.3998 |
| ebitMargin: | 24.8171 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 14.7868 | preTaxROA: | 8.1524 |
| roe: | 12.2082 | roa: | 6.7307 |
| netIncomeGrowth: | -17.4385 | revenuesGrowth: | -4.8936 |
| taxExpenseRate: | 17.4385 | equityTurnover: | 0.6178 |
| epsBasic: | 1.9375 | epsBasicGrowth: | -17.3333 |
| incomeBeforeTaxes: | 512.6000 | priceEarningsRatioCompany: | 25.2581 |
| priceCashFlowRatio: | 14.9478 | bookValuePerShare: | 15.8674 |
| marketCap: | 10691567460.0000 | earningsYield: | 3.9591 |
| pegRatio: | -1.4572 | cashFlowPerShare: | 3.2739 |
| netAssetsPerShare: | 15.8674 | priceBookValueRatio: | 3.0842 |
| priceEarningsRatio: | 25.2630 | netEarningsPerShare: | 1.9371 |
| currency: | USD |
| year: | 2023 | units: | 1000000 |
| balanceSheetTotal: | 6115.1900 | cash: | 668.0800 |
| currentAssets: | 2147.5600 | fixedAssets: | 3967.6300 |
| liabilities: | 1079.2900 | nonCurrentLiabilities: | 1228.1300 |
| totalShareholdersEquity: | 3807.7600 | employees: | 5967 |
| property: | 765.0300 | intangibleAssets: | 526.8200 |
| inventories: | 398.9800 | accountsReceivable: | 381.8700 |
| accountsPayable: | 84.1500 | liabilitiesTotal: | 2307.4200 |
| longTermDebt: | 921.8200 | shortTermDebt: | 587.9700 |
| minorityInterests: | 0.0000 | sales: | 1965.3100 |
| netIncome: | 341.3000 | operatingResult: | 409.9300 |
| incomeInterest: | 25.5800 | investments: | 198.5100 |
| incomeTaxes: | 88.5000 | costGoodsSold: | 731.6200 |
| grossProfit: | 1233.6900 | minorityInterestsProfit: | 0.0000 |
| cashFlow: | 459.4500 | cashFlowInvesting: | -87.6500 |
| cashFlowFinancing: | -433.8200 | accountingStandard: | US GAAP |
| epsBasic: | 1.5000 | incomeBeforeTaxes: | 429.8000 |
| currency: | USD |
| year: | 2024 | priceEarningsRatioCompany: | 27.7314 |
| priceCashFlowRatio: | 20.6607 | bookValuePerShare: | 16.6859 |
| marketCap: | 9492573961.0243 | earningsYield: | 3.6060 |
| cashFlowPerShare: | 2.0133 | netAssetsPerShare: | 16.6859 |
| priceBookValueRatio: | 2.4930 | priceEarningsRatio: | 27.8130 |
| netEarningsPerShare: | 1.4956 | currency: | USD |
Finanzen (ausführlich)
| year: | 2022 |
| units: | 1000000 |
| balanceSheetTotal: | 6287.7300 |
| cash: | 730.6600 |
| currentAssets: | 2393.9500 |
| fixedAssets: | 3893.7800 |
| liabilities: | 974.5200 |
| nonCurrentLiabilities: | 1846.6000 |
| totalLiabilitiesEquity: | 6287.7300 |
| provisions: | 486.2300 |
| totalShareholdersEquity: | 3466.6100 |
| employees: | 6178 |
| property: | 662.1700 |
| intangibleAssets: | 544.7900 |
| inventories: | 357.9600 |
| accountsReceivable: | 323.7500 |
| accountsPayable: | 98.7300 |
| liabilitiesTotal: | 2821.1200 |
| longTermDebt: | 1474.8900 |
| shortTermDebt: | 389.5500 |
| minorityInterests: | 0.0000 |
| sales: | 2141.5100 |
| netIncome: | 423.2100 |
| operatingResult: | 531.4600 |
| incomeInterest: | -25.6000 |
| investments: | 189.8500 |
| incomeTaxes: | 89.3900 |
| costGoodsSold: | 756.9500 |
| grossProfit: | 1384.5600 |
| minorityInterestsProfit: | 0.0000 |
| revenuePerEmployee: | 346634.8333 |
| cashFlow: | 715.2600 |
| cashFlowInvesting: | -726.7600 |
| cashFlowFinancing: | -125.8000 |
| accountingStandard: | US GAAP |
| equityRatio: | 55.1329 |
| debtEquityRatio: | 81.3798 |
| liquidityI: | 74.9764 |
| liquidityII: | 108.1979 |
| netMargin: | 19.7622 |
| grossMargin: | 64.6534 |
| cashFlowMargin: | 33.3998 |
| ebitMargin: | 24.8171 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 14.7868 |
| preTaxROA: | 8.1524 |
| roe: | 12.2082 |
| roa: | 6.7307 |
| netIncomeGrowth: | -17.4385 |
| revenuesGrowth: | -4.8936 |
| taxExpenseRate: | 17.4385 |
| equityTurnover: | 0.6178 |
| epsBasic: | 1.9375 |
| epsBasicGrowth: | -17.3333 |
| incomeBeforeTaxes: | 512.6000 |
| priceEarningsRatioCompany: | 25.2581 |
| priceCashFlowRatio: | 14.9478 |
| bookValuePerShare: | 15.8674 |
| marketCap: | 10691567460.0000 |
| earningsYield: | 3.9591 |
| pegRatio: | -1.4572 |
| cashFlowPerShare: | 3.2739 |
| netAssetsPerShare: | 15.8674 |
| priceBookValueRatio: | 3.0842 |
| priceEarningsRatio: | 25.2630 |
| netEarningsPerShare: | 1.9371 |
| currency: | USD |
| year: | 2023 |
| units: | 1000000 |
| balanceSheetTotal: | 6115.1900 |
| cash: | 668.0800 |
| currentAssets: | 2147.5600 |
| fixedAssets: | 3967.6300 |
| liabilities: | 1079.2900 |
| nonCurrentLiabilities: | 1228.1300 |
| totalShareholdersEquity: | 3807.7600 |
| employees: | 5967 |
| property: | 765.0300 |
| intangibleAssets: | 526.8200 |
| inventories: | 398.9800 |
| accountsReceivable: | 381.8700 |
| accountsPayable: | 84.1500 |
| liabilitiesTotal: | 2307.4200 |
| longTermDebt: | 921.8200 |
| shortTermDebt: | 587.9700 |
| minorityInterests: | 0.0000 |
| sales: | 1965.3100 |
| netIncome: | 341.3000 |
| operatingResult: | 409.9300 |
| incomeInterest: | 25.5800 |
| investments: | 198.5100 |
| incomeTaxes: | 88.5000 |
| costGoodsSold: | 731.6200 |
| grossProfit: | 1233.6900 |
| minorityInterestsProfit: | 0.0000 |
| cashFlow: | 459.4500 |
| cashFlowInvesting: | -87.6500 |
| cashFlowFinancing: | -433.8200 |
| accountingStandard: | US GAAP |
| epsBasic: | 1.5000 |
| incomeBeforeTaxes: | 429.8000 |
| currency: | USD |
| year: | 2024 |
| priceEarningsRatioCompany: | 27.7314 |
| priceCashFlowRatio: | 20.6607 |
| bookValuePerShare: | 16.6859 |
| marketCap: | 9492573961.0243 |
| earningsYield: | 3.6060 |
| cashFlowPerShare: | 2.0133 |
| netAssetsPerShare: | 16.6859 |
| priceBookValueRatio: | 2.4930 |
| priceEarningsRatio: | 27.8130 |
| netEarningsPerShare: | 1.4956 |
| currency: | USD |
